Clinical Trials Browser

Phase 2 × Leukemia, Myeloid, Acute × Succimer × Clear all

NCT06811233 2025-10-24

Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute